[ET Net News Agency, 30 April 2025] HANSOH PHARMA (03692) rose 3.2% to HK$24.3.
It hits an intra-day high of HK$24.3, and an intra-day low of HK$23.65. The total shares
traded was 2.27 million, with a value of HK$54.41m. The active buy/sell ratio is 56:44,
with net buying turnover of HK$6.04m. CLSA LTD accounts for greatest net responsive buying
turnover of HK$4.24m, with volume weighted average price of HK$23.995. CHINA INV INFO
accounts for greatest net responsive selling turnover of HK$4.92m, with volume weighted
average price of HK$24.013. The stock has risen a combined 4.5% over the past 2
consecutive trading days.
The Hang Seng Index now fell 17 points, or less than 0.1% to 21,990.

Basic Information
=================

---------------------------------
Nominal 24.300 % Chg +3.18%
High 24.300 Low 23.650
Shares Tr 2.27m Turnover 54.41m
10-D SMA 23.280 %H.V 67.874
20-D SMA 23.053 VWAP 24.005
50-D SMA 20.896 RSI14 62.428
---------------------------------
Status: Active buy/sell ratio is 56:44, with net buying turnover of HK$6.04m, rising a
combined 4.5% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 24.30 +3.18
SIHUAN PHARM (00460) 0.72 -1.37
GRAND PHARMA (00512) 6.10 +2.35
SINO BIOPHARM (01177) 3.90 +0.26
LIVZON PHARMA (01513) 25.95 +0.19
LUYE PHARMA (02186) 2.01 Unchanged
FOSUN PHARMA (02196) 14.14 -2.62
SH PHARMA (02607) 10.62 +0.19
CHINARES PHARMA (03320) 4.91 -0.20
GOLDEN THROAT (06896) 4.30 Unchanged
-----------------------------------------------
(ed)